High Potency Drugs – from Molecule to Market
PCI Pharma Services has invested in state-of-the-art containment equipment and created a ‘Potent Passport’ philosophy to identify the specific handling... View Article
PCI Pharma Services has invested in state-of-the-art containment equipment and created a ‘Potent Passport’ philosophy to identify the specific handling... View Article
Making Clinical Trials More Effective By Keeping Focus On The Patient – A Q&A with Justin Schroeder, Executive Director, Marketing,... View Article
The Challenge and Opportunity of Distributing Temperature-Sensitive Biopharmaceuticals and Cell Therapies Distributing sensitive biopharmaceuticals and cell therapies is a complex... View Article
The journey from discovery laboratory to pharmacy shelf is long and arduous, particularly for highly potent APIs, which must be... View Article
Successfully managing the demands of cell therapy supply chains – addressing the unique complexity of an autologous therapy supply chain... View Article
A controlled substance is a drug or chemical whose manufacture, possession or distribution is highly regulated by the government and... View Article
Justin Schroeder Discusses Outlook On Pharma Market With Pharmtech CMO executives share their opinions on where outsourcing is going and... View Article
Featured in Journal of Clinical Trials, Volume 7, pages 60-61 Gavin Morgan, Manager of Global Logistics Over the last ten... View Article
Bottling Line Expansion to Support Customer Needs
Rockford, IL Commercial Packaging site to add nearly 100 million units of bottling line capacity PCI is pleased to announce... View Article
Angi Calkins Appointed as Chief Human Resources Officer
Calkins to lead global human resource team during time of considerable expansion PCI is pleased to announce the appointment of... View Article
x